Recent Quotes (30 days)

You have no recent quotes
chg | %

Nextgen Biomed Ltd  

(Public, TLV:NXGN)   Watch this stock  
Find more results for NXGN
-1.40 (-7.82%)
Apr 27 - Close
TLV data delayed by 20 mins - Disclaimer
Currency in ILA unless noted
Range 16.50 - 16.50
52 week 0.15 - 16.50
Open 16.50
Vol / Avg. 49,048.00/11,657.00
Mkt cap 4.78M*
P/E     -
Div/yield     -
EPS -0.11*
Shares 28.99M
Beta     -
Inst. own     -
May 14, 2017
Nextgen Biomed Ltd Annual Shareholders Meeting - 12:00PM GMT+3 - Add to calendar

Key stats and ratios

Q3 (Sep '16) 2015
Net profit margin - -
Operating margin - -
EBITD margin - -
Return on average assets -47.06% -150.16%
Return on average equity -57.96% -886.27%
Employees 187 -
CDP Score - -


floor 22 Tower Round Center A
+972-3-6070320 (Phone)
+972-3-6070323 (Fax)

Website links


Nextgen Biomed Ltd., formerly Sela Group.Com Ltd., is an Israel-based company. Previously, the Company provided training and services to the Israeli and global high technology sector, software development, digital hardware design, information security, management of computing systems, information technology (IT), personnel positioning, consultancy, outsourcing, Website casting and Website conferencing in Israel and abroad. The Company's clients included the Israeli Defense Ministry, Raphael, Elisra, Avirnaoutic Industry, Amdocs, BMC, Comverse, Texas Instruments, The National Israeli Electricity Company, General Health Services Company, Bank Leumi, Pelephone, EDS, NDS, ECI Telecom and others. Currently, Nextgen Biomed Ltd. via its subsidiary, Sindolor Medical Ltd., operates research and development of injection devices while reducing pain.

Officers and directors

Avraham Katzav Chief Executive Officer, Vice President - Finance
Age: 47
Shlomo Zakai Member of the Management Board
Yinon Arieli Director
Age: 41
Itzhak Israel Director
Age: 37
Erez Goldschmidt External Director
Age: 43
Eli Arad Independent Director
Age: 40
Eti Cohen Independent Director